Restorative neurostimulation may improve pain, disability, and quality of life in chronic low back pain. Read more.

--CY 2026 Outpatient Prospective Payment System (OPPS) Final Rule moves RNS replacement procedures to highest-paying neurostimulator APC-- NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company ...

The US Food and Drug Administration (FDA) has cleared NeurAxis’ percutaneous electrical nerve field stimulation (PENFS) system for treating pain linked with a chronic type of gastrointestinal disorder ...

Pilot study evaluates safety and tolerability of implantable neuromodulation therapy for erectile dysfunction following radical prostatectomy LAUSANNE, Switzerland, Oct. 01, 2025 (GLOBE NEWSWIRE) -- ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

After a twitching pinky finger led to a diagnosis of young-onset Parkinson’s disease, Keith Krehbiel, then 42, stopped at a bookstore on the way home to learn more about the progressive neurological ...

With its FDA-approved neurostimulator implant aimed at helping patients recover from stroke, MicroTransponder has raised $65 million in venture capital funding to expand its commercial reach. The ...

On Wednesday, Vivani Medical, Inc. (NASDAQ:VANI) said it intends to spin off Cortigent, Inc., a division that develops brain implant devices to help people recover critical body functions, as an ...

Henry Goolsby, MD, his wife, Patricia Lenae Goolsby, and their clinic, Infinite Health Integrative Medical Center, agreed to pay $450,000 to settle allegations of improper Medicare billing. From ...

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive technology personalizing treatment of Parkinson’s symptoms using advanced ...